Send feedback

COL6A3 p.Arg2811Cys

c.8431C>T · rs371361651 · VCV1034842

Uncertain significance Multiple submitters
Classification
Uncertain significance
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 2 submitters
AlphaMissense
likely pathogenic
0.6741 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.0039%, nfe)
Missense predictors
2/2 damaging
AlphaMissense, REVEL
Conditions
1
Bethlem myopathy 1A

Computational evidence

Protein change
AlphaMissense0.6741likely pathogenic
REVEL0.812moderately pathogenic-leaning
⇒ AlphaMissense and REVEL both call this damaging.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 12GERP 1.7, phastCons 1
Regional constrainto/e 0.95unconstrained · MANE · 34 kb · p 0.074 · regional, not allelic
Overall
CADD29.5PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean damaging — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.0039% European (non-Finnish) · 46/1,180,040 alleles
Filtering AF 0.00299% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.00267%
Overall 0.00316% 51/1,613,658 alleles · very rare
Ancestry group Frequency 1 in
Remaining individualsnot grpmax-eligible 0.0048% 20,826
European (non-Finnish)grpmax 0.0039% 25,653
Admixed American 0.00167% 60,006
South Asian 0.0011% 91,084

Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
COL6A3
Protein
p.Arg2811Cys
Coding
c.8431C>T
MANE Select
NM_004369
dbSNP
rs371361651
Type
single nucleotide variant
Location
chr2:237340485 (GRCh38)
Gene constraint
LOEUF 0.564 · pLI <0.01 (gnomAD)
Residue 2811
the vwfa 12 domain; an α-helix; the 'nonhelical region' region
Full COL6A3 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

Bethlem myopathy 1A — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

For Bethlem muscular dystrophy (Orphanet):

Inheritance
Autosomal dominant, Autosomal recessive
Onset
Childhood, Infancy
Prevalence
1-9 / 1 000 000 (United Kingdom)

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/col6a3-p-arg2811cys (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown